Jincan He

776 total citations
20 papers, 594 citations indexed

About

Jincan He is a scholar working on Molecular Biology, Immunology and Neurology. According to data from OpenAlex, Jincan He has authored 20 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Neurology. Recurrent topics in Jincan He's work include Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Retinal Diseases and Treatments (3 papers) and Inflammation biomarkers and pathways (3 papers). Jincan He is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Retinal Diseases and Treatments (3 papers) and Inflammation biomarkers and pathways (3 papers). Jincan He collaborates with scholars based in China, United States and Netherlands. Jincan He's co-authors include Gongke Li, Xiangming Mao, Wei Zhao, Ziqing Wu, Yuling Hu, Zhuoxing Gao, Weixin Chen, Jianwei Dong, Yufei Hu and Bing Lu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Journal of Hazardous Materials.

In The Last Decade

Jincan He

18 papers receiving 592 citations

Peers

Jincan He
Comparison fields: 5 of 77
  • Molecular Biology 422
  • Cancer Research 181
  • Biomedical Engineering 85
  • Materials Chemistry 59
  • Oncology 55
Replace Zilong Zhou with:
Zilong Zhou China
Chenfei Kong China
Guancheng Li China
Lifang Yao China
Yongyou Wu China
Saleh Ramezani United States
Jiajia Cui United States
Yixin Liu Taiwan
Zilong Zhou China View profile →
Citations per field, relative to Jincan He
Jincan He · 1×
Citations per year, relative to Jincan He
Jincan He · 1×

Countries citing papers authored by Jincan He

Since Specialization
Citations

This map shows the geographic impact of Jincan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jincan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jincan He more than expected).

Fields of papers citing papers by Jincan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jincan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jincan He. The network helps show where Jincan He may publish in the future.

Co-authorship network of co-authors of Jincan He

This figure shows the co-authorship network connecting the top 25 collaborators of Jincan He. A scholar is included among the top collaborators of Jincan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jincan He. Jincan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 8
3 2
4 7
5 20
6 14
7 2
8 60
9 0
10 102
11 27
12 35
13 30
14 17
15 71
16 7
17 49
18
[Establishing a mouse model of Sertoli-cell-only syndrome by administration of busulfan].
5
19 37
20 101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026